AdMSC

DRUG3 trials

Sponsors

University Hospital, Toulouse, Paul E Schulz

Conditions

Cognitive DysfunctionSystemic SclerodermaSystemic Sclerosis

Phase 1

Stem Cell Therapy for Early Alzheimer's Disease

RecruitingNCT06775964

Paul E SchulzCognitive Dysfunction

Start: 2026-03-11End: 2028-01-01Target: 12Updated: 2026-04-20

Phase 2

Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.

RecruitingNCT04356755

University Hospital, ToulouseSystemic Sclerosis

Start: 2020-09-22End: 2027-03-31Target: 32Updated: 2025-12-31

Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma

Not yet recruitingNCT07326033

University Hospital, ToulouseSystemic Scleroderma

Start: 2026-01-31End: 2028-07-31Target: 50Updated: 2026-01-08